1: (ROOT (NP (NP (NN Factbox)) (: :) (: ..) (NP (NP (NP (CD COVI-19) (NN Test)) (: -) (SBAR (WHNP (WP What)) (S (VP (VBZ 's) (ADVP (IN Out) (RB There)))))) (CC and) (WHADVP (WRB How)))))
2: (ROOT (S (: -) (NP (NML (NN Health) (NN policy)) (NNS experts)) (VP (VBP say) (SBAR (S (NP (DT the) (NNP United) (NNPS States)) (VP (MD must) (ADVP (RB dramatically)) (VP (VB increase) (NP (NP (DT the) (NN availability)) (PP (IN of) (NP (NP (NNS tests)) (PP (IN for) (NP (DT the) (NN coronavirus)))))) (SBAR (IN if) (S (NP (PRP it)) (VP (VBZ is) (S (VP (TO to) (ADVP (RB safely)) (VP (VB reopen) (NP (PRP$ its) (NN economy))))))))))))) (. .)))
3: (ROOT (S (-LRB- ..) (S (S (NP (NNS regulators)) (VP (VBP have) (VP (VBN moved) (ADVP (RB speedily)) (S (VP (TO to) (VP (VB authorize) (NP (JJ many) (JJ new) (NNS tests)))))))) (, ,) (CC but) (S (NP (NNS concerns)) (ADVP (RB still)) (VP (VBP remain) (PP (IN about) (NP (NP (NNS tests) (POS ')) (NN accuracy)))))) (, ,) (CC and) (S (NP (DT some) (NNS policymakers)) (VP (VBP say) (SBAR (S (NP (JJ new) (NN testing) (NNS technologies)) (VP (VBP need) (S (VP (TO to) (VP (VB proliferate)))) (S (VP (TO to) (ADVP (RB fully)) (VP (VB contain) (NP (DT the) (NN virus)))))))))) (. .)))
4: (ROOT (S (NP (JJ MOLECULAR) (NNP DIAGNOSTIC) (JJ TESTSMolecular) (JJ diagnostic) (NNS tests)) (VP (VBP show) (SBAR (WHNP (WP who)) (S (VP (VBZ has) (VP (VBN contracted) (NP (DT the) (NN virus))))))) (. .)))
5: (ROOT (S (NP (JJS Most)) (VP (VBP rely) (PP (IN on) (NP (NP (NNS samples)) (VP (VBN collected) (PP (IN from) (NP (NP (NNS patients)) (VP (VBG using) (NP (JJ nasal) (NNS swabs))))))))) (. .)))
6: (ROOT (S (NP (DT The) (NNS samples)) (VP (VBP are) (ADVP (RB then)) (VP (VBN analyzed) (S (VP (VBG using) (NP (NP (NP (DT a) (NN method)) (VP (VBN called) (S (NP (NN polymerase) (NN chain) (NN reaction))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ detects) (NP (JJ viral) (NN RNA)))))))))) (. .)))
7: (ROOT (S (NP (DT These) (NNS tests)) (VP (MD can) (VP (VB be) (ADJP (RB highly) (JJ accurate)) (, ,) (S (PP (IN in) (NP (DT some) (NNS instances))) (VP (VBG detecting) (NP (DT the) (NN virus)) (PP (IN in) (NP (NP (CD 95) (NN %)) (PP (IN of) (NP (NNS cases))))))))) (. .)))
8: (ROOT (S (NP (NP (DT The) (JJ first) (JJ diagnostic) (NNS tests)) (SBAR (S (VP (TO to) (VP (VB get) (SYM ..) (NP (JJ regulatory) (NN approval))))))) (VP (VBD required) (SBAR (IN that) (S (NP (DT a) (NN sample)) (VP (VB be) (VP (VBN shipped) (ADVP (RB back) (PP (IN to) (NP (DT a) (NN laboratory)))) (S (VP (TO to) (VP (VB be) (VP (VBN analyzed))))))))) (, ,) (S (VP (VBG slowing) (NP (NP (DT the) (NN speed)) (SBAR (WHPP (IN at) (WHNP (WDT which))) (S (NP (NNS patients)) (VP (MD could) (VP (VB receive) (NP (NNS results)))))))))) (. .)))
9: (ROOT (S (NP (ADJP (ADVP (RBR More) (RB recently)) (VBN approved)) (JJ diagnostic) (NNS tests)) (VP (MD can) (VP (VP (VB be) (VP (VBN conducted) (PP (IN at) (NP (NP (DT the) (JJ same) (NN location)) (SBAR (WHADVP (WRB where)) (S (NP (DT the) (NN sample)) (VP (VBZ is) (VP (VBN taken))))))))) (CC and) (VP (VB provide) (NP (NNS results)) (PP (IN in) (NP (NNS minutes)))))) (. .)))
10: (ROOT (NP (: Examples:-) (NP (NNP Roche) (NNP cobas)) (NNP SAR) (HYPH -) (VBN Co-2Authorized) (PP (IN for) (NP (NP (NN use)) (PP (IN by)))) (. ..)))
11: (ROOT (S (NP (PRP It)) (VP (VBZ requires) (SBAR (S (NP (NP (DT a) (NN sample)) (VP (VBN taken) (PP (IN by) (NP (JJ nasal) (NN swab))))) (VP (VB be) (VP (VBN sent) (ADVP (RB back) (PP (IN to) (NP (DT a) (NN lab)))) (PP (IN for) (NP (NN analysis)))))))) (. .)))
12: (ROOT (S (NP (NNP Roche)) (VP (VBZ says) (SBAR (S (NP (NNS studies)) (VP (VBP show) (SBAR (S (NP (PRP it)) (VP (MD can) (VP (VB detect) (NP (NP (ADJP (RB very) (JJ low)) (NNS levels)) (PP (IN of) (NP (DT the) (NN virus)))) (PP (IN with) (NP (NML (CD 95) (NN %)) (NN accuracy))))))))))) (. .)))
13: (ROOT (S (S (NP (NNP Abbott) (NNP ID)) (ADVP (RB Now)) (VP (VBN Approved) (PP (IN in) (NP (JJ late) (NNP March))))) (, ,) (NP (NP (NNP Abbott) (POS 's)) (JJ rapid) (, ,) (NML (NN poin) (HYPH -) (NP (IN o) (HYPH -) (NN care))) (JJ molecular) (JJ diagnostic) (NN test)) (VP (MD can) (VP (VB provide) (NP (NNS results)) (PP (IN on) (NP (NN site))) (PP (IN to) (NP (NNS patients))) (PP (IN within) (NP (NNS minutes))))) (. .)))
14: (ROOT (S (PP (IN As) (PP (IN of) (NP (NNP May) (CD 4)))) (, ,) (NP (NNP Abbott)) (VP (VBD said) (SBAR (S (NP (PRP it)) (VP (VP (VBZ is) (VP (VBG producing) (NP (NP (CD 5,000)) (PP (IN of) (NP (DT these) (NNS tests))) (PP (IN per) (NP (NN day)))))) (, ,) (CC and) (VP (VBZ plans) (S (VP (TO to) (VP (VB ramp) (NP (QP (RB up) (IN to) (CD 2) (CD million))) (PP (IN by) (NP (NNP June))))))))))) (. .)))
15: (ROOT (S (NP (NP (DT A) (NN study)) (VP (VBN conducted) (PP (IN by) (NP (DT the) (NNP Cleveland) (NNP Clinic))))) (VP (VBD showed) (SBAR (S (NP (DT the) (NN test)) (VP (VBD detected) (NP (DT the) (NN virus)) (PP (IN in) (NP (NP (QP (RB around) (CD 85)) (NN %)) (PP (IN of) (NP (NNS cases))))))))) (. .)))
16: (ROOT (S (NN ANTIGEN) (ADVP (RBR TESTSEarlier)) (DT this) (NN month) (, ,) (FW ..) (NP (NNS regulators)) (VP (VBD authorized) (NP (NP (DT the) (JJ first) (JJ antigen) (NN test)) (, ,) (NP (NP (DT a) (JJ new) (NN category)) (PP (IN of) (NP (JJ diagnostic) (NN test)))))) (. .)))
17: (ROOT (S (NP (NP (DT This) (NN type)) (PP (IN of) (NP (NN test)))) (VP (VBZ scans) (PP (IN for) (NP (NP (NNS proteins)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB be) (VP (VBN found) (PP (IN on) (CC or) (IN inside) (PP (IN of) (NP (DT a) (NN virus)))))))))))) (. .)))
18: (ROOT (S (NP (PRP They)) (VP (VBP test) (NP (NP (NNS samples)) (VP (VBN taken) (PP (IN from) (NP (DT the) (JJ nasal) (NN cavity))))) (S (VP (VBG using) (NP (NNS swabs))))) (. .)))
19: (ROOT (S (NP (NN Antigen) (NNS tests)) (VP (VP (MD can) (VP (VB detect) (NP (DT the) (NN virus)) (ADVP (RB very) (RB quickly)))) (CC and) (VP (MD can) (ADVP (RB potentially)) (VP (VB be) (VP (VBN produced) (PP (IN at) (NP (JJR lower) (NN cost))))))) (. .)))
20: (ROOT (S (NP (DT The) (. ..) (NML (NNP Food) (CC and) (NNP Drug)) (NNP Administration)) (VP (VBZ says) (SBAR (S (NP (NML (JJ antigen) (NN test)) (NN production)) (VP (MD can) (ADVP (RB potentially)) (VP (VB scale) (PP (IN to) (NP (NP (NNS millions)) (PP (IN per) (NP (NN day)))))))))) (. .)))
21: (ROOT (S (CC But) (NP (PRP they)) (VP (VBP produce) (NP (JJ false) (NNS negatives)) (PP (IN at) (NP (NP (DT a) (JJR higher) (NN rate)) (PP (IN than) (NP (NML (JJ molecular) (NNS diagnostics)) (NNS tests)))))) (. .)))
22: (ROOT (S (: Examples:-) (NP (NP (NNP Quidel) (NNP Corporation) (NNP Sofia) (CD 2) (NNP SARS) (NNP Antigen)) (VP (VBN FIAAuthorized) (IN for) (NP (NP (NN use)) (NP (ADVP (RBR earlier)) (DT this) (NN month))))) (, ,) (NP (NNP Quidel)) (VP (VBD said) (SBAR (S (NP (DT the) (NN test)) (VP (VBZ picks) (PRT (RP up)) (NP (NP (QP (RB around) (CD 80)) (NN %)) (PP (IN of) (NP (CD COVI-19) (NNS cases)))))))) (. .)))
23: (ROOT (S (NP (NN ANTIBODY) (NN TESTSAntibody) (NNS tests)) (VP (VP (VBP take) (NP (NP (JJ small) (NNS samples)) (PP (IN of) (NP (NP (NNS patients) (POS ')) (NN blood))))) (CC and) (VP (VBP scan) (NP (PRP them)) (PP (IN for) (NP (NP (NNS antibodies)) (, ,) (SBAR (WHNP (WDT which)) (S (NP (DT the) (JJ immune) (NN system)) (VP (VBZ produces) (PP (IN in) (NP (NP (NN response)) (PP (IN to) (NP (DT a) (NN virus)))))))))))) (. .)))
24: (ROOT (S (NP (PRP They)) (VP (MD can) (VP (VB be) (VP (VBN conducted) (PP (PP (IN in) (NP (NNS labs))) (CC or) (PP (IN through) (NP (NP (NML (NN o) (HYPH -) (NN site)) (NNS tests)) (SBAR (WHNP (WDT that)) (S (VP (VBP provide) (NP (NNS results)) (PP (IN in) (NP (NNS minutes)))))))))))) (. .)))
25: (ROOT (S (NP (NP (NN Antibody) (NNS tests)) (, ,) (VP (ADVP (RB also)) (VBN known) (PP (IN as) (NP (JJ serological) (NNS tests)))) (, ,)) (VP (VBP are) (RB not) (ADJP (ADJP (RB as) (JJ effective)) (PP (IN as) (NP (JJ molecular) (JJ diagnostic) (NNS tests)))) (PP (IN in) (S (VP (VBG catching) (NP (HYPH COVI-19)) (PP (IN at) (NP (NP (NN earl) (HYPH -) (NNS stages)) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (NNS patients)) (VP (MD may) (RB not) (ADVP (RB yet)) (VP (VB be) (VP (VBG producing) (NP (NNS antibodies))))))))))))) (. .)))
26: (ROOT (S (CC But) (NP (PRP they)) (VP (MD can) (VP (VB confirm) (SBAR (IN if) (S (NP (NNS patients)) (ADVP (RB previously)) (VP (VP (VBD had) (NP (DT the) (NN virus))) (CC and) (VP (VBP have) (NP (NP (NNS antibodies)) (SBAR (WHNP (WDT that)) (S (VP (MD might) (VP (VB protect) (NP (PRP them)) (PP (IN against) (NP (JJ future) (NN infection)))))))))))))) (. .)))
27: (ROOT (S (NP (DT The) (NNP FDA)) (ADVP (RB recently)) (VP (VBD tightened) (NP (NP (NNS rules)) (PP (IN on) (NP (NML (JJ serological) (NN test)) (NNS developers)))) (SBAR (IN after) (S (NP (NP (DT a) (NN proliferation)) (PP (IN of) (NP (JJ unauthorized) (NNS tests)))) (VP (VBD raised) (NP (NP (NNS questions)) (PP (IN about) (NP (PRP$ their) (NN reliability)))))))) (. .)))
28: (ROOT (S (NP (NNS Researchers)) (VP (VBP have) (RB not) (VP (VBN confirmed) (SBAR (IN whether) (S (NP (NP (VBN recovered) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP are) (VP (VBG producing) (NP (NNS antibodies))))))) (VP (VBP are) (ADJP (RB fully) (JJ immune) (PP (IN to) (NP (CD COVI-19))))))))) (. .)))
29: (ROOT (S (: Examples:-) (NP (NP (NML (NNP Abbott) (NNP Architect)) (NNP SAR) (HYPH -) (NNP Co-2) (NNP IgG) (NNPS AssayResearchers)) (PP (IN at) (NP (NP (DT the) (NML (NML (NNP University)) (PP (IN of) (NP (NNP Washington)))) (NNP School)) (PP (IN of) (NP (NNP Medicine)))))) (VP (VBP say) (SBAR (S (NP (NP (DT the) (NN test)) (, ,) (SBAR (WHNP (WDT which)) (S (NP (NNP Abbott)) (VP (VBD launched) (PP (IN in) (NP (NNP April)))))) (, ,)) (VP (VBZ has) (NP (NP (NP (DT a) (NN specificity)) (PP (IN of) (NP (CD 9.9) (NN %)))) (CC and) (NP (NP (DT a) (NN sensitivity)) (PP (IN of) (NP (CD 100) (NN %))))) (, ,) (S (VP (VBG suggesting) (NP (NP (ADJP (RB very) (JJ few)) (JJ false) (NNS positives)) (CC and) (NP (DT no) (JJ false) (NNS negatives))))))))) (. .)))
30: (ROOT (S (NP (NNP Abbott)) (VP (VBZ has) (ADVP (RB already)) (VP (VBN shipped) (NP (QP (JJR more) (IN than) (CD 10) (CD million)) (NN antibody) (NNS tests)) (PP (IN to) (NP (NNS hospitals) (CC and) (NNS labs))))) (. .)))
